-
Most Recent
Search Results
240 results for anx
Broadcom’s $10 Billion Mic-Drop: A Turning Point in AI Investing
Broadcom just secured a $10-billion XPU deal, signaling the shift from GPUs to custom AI chips and redefining the future of AI compute.
What Sandy Koufax’s Perfect Game Taught Me About Investing
As a native Californian and avid Dodgers fan, it may not come as a surprise that Sandy Koufax happens to be my all-time favorite baseball…
Fed’s ‘Risk-Management’ Cut Sets the Stage for Tech’s Next Boom
With the Fed-induced drop in mortgage rates, Opendoor’s core business of buying and selling homes could hit the gas. When borrowing costs fall and homebuyers…
Down a Lot, Up a Little and 10X Winners
Often, a stock that looks like no more than a pile of ashes can make a comeback – and make foresighted investors rich. Global macro…
5 All-In Summit Tech Trends Driving the Next Boom
Tech leaders at the All-In Summit—from Elon Musk to Palantir’s Alex Karp—unveiled groundbreaking shifts in AI, finance, energy, and space. Investor Luke Lango shares five…
Hottest Services Stocks Now – ANN ANF HPP LULU
Services stocks finished down 0.2% on Wall Street on Friday.
Hottest Technology Stocks Now – SLH ASX SNX RAX
Technology stocks fell broadly on Wall Street on Thursday morning, with the sector seeing an overall decline of 1.0%.
2 Undervalued Big Bank Stocks to Buy
Large bank stocks exceeded forecasts last quarter and could outperform for the balance of 2014. Citigroup (C) and Bank of America (BAC) also feature attractive…
5 College Degrees That Are Great Investments
Find out which college degrees have the highest return on investment compared to university costs and student loan debt
Why Is AN2 Therapeutics (ANTX) Stock Down 35% Today?
AN2 Therapeutics stock is down on Friday after ANTX investors learned of the company terminating its EBO-301 Phase 2/3 clinical trial.
Barrick Gold Set to Shine
Purchasing ABX now and on any pullback could provide substantial reward.
ANTX Stock Earnings: AN2 Therapeutics Beats EPS for Q2 2024
ANTX stock results show that AN2 Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
ANTX Stock Earnings: AN2 Therapeutics Beats EPS for Q4 2023
ANTX stock results show that AN2 Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
ANTX Stock Earnings: AN2 Therapeutics Beats EPS for Q1 2024
ANTX stock results show that AN2 Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
ChatGPT Was Just the Beginning. The Real Shift Starts Now.
The smart money is rotating into the AI robotics stack. And if history is any guide, this trade could be the biggest yet…
The August Jobs Report Spooked Wall Street, But History Says Buy
Wall Street panicked on the August jobs report. But history shows labor market weakness plus Fed cuts often mark the start of major rallies.
This Quant Tool Turns the Tables on Wall Street
If you’re a regular reader of mine, then you know that I began using quantitative analysis in my stock-picking decades ago. And today, practically every…
Google Ruling Sends a Signal: Courts Favor Behavioral Tweaks, Not Breakups
AI gave Google a lifeline: The court opts for tweaks, not breakup. Read why this ruling shifts the regulatory landscape and bolsters Big Tech.
Sell Into Any Rally This Week
We may see a bounce, but the downtrend is still intact.
AnnTaylor Out of Fashion?
AnnTaylor Stores Corp. (ANN) released operating results for the 2008 fiscal year and fourth-quarter ending January 31 that far exceeded the losses expected by analysts.
CNX Stock Earnings: CNX Resources Beats EPS, Misses Revenue for Q2 2024
CNX stock results show that CNX Resources beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
4 – 10 of 240 results
